drugset / Trial / NCT00991562
IMGN901 in Combination With Lenalidomide and Dexamethasone
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to test IMGN901 in combination with lenalidomide and dexamethasone every 28 days.
Timeline
- Start
- 2009-12
- Primary completion
- 2013-08
- Completion
- 2014-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lorvotuzumab Mertansine | Monoclonal antibody | — | — |